Brian Doerner > Ballard Spahr LLP > Philadelphia, United States > Lawyer Profile

Ballard Spahr LLP
1735 MARKET STREET, 51ST FLOOR
PHILADELPHIA, PA 19103-7599
PENNSYLVANIA
United States

Work Department

Business and Transactions

Position

Partner and Practice Co-Leader of the Mergers and Acquisitions Group

Career

Brian D. Doerner is a Practice Co-Leader of the Mergers and Acquisitions Group. Brian also is the former Chair of the Business and Transactions Department, former Co-Leader of the Life Sciences Industry Group, and he served for six months as the interim general counsel for a NYSE-listed multinational company.

Brian has over 30 years of experience representing both public and private companies in mergers and acquisitions, restructurings, cross-border transactions, and corporate governance matters. He has negotiated numerous strategic alliances and licensing agreements for life sciences, technology, manufacturing, and other companies. In the area of securities law, Brian has handled numerous private placements, private equity transactions, tender offers, initial public offerings, follow-on offerings, and 144A transactions.

Admissions: Pennsylvania

Memberships

Entrepreneurs’ Forum, past President and Director

Philadelphia Bar Association, Business Law Section

Life Sciences PA, Board Advocacy Committee

People’s Light & Theatre Company, Former President, Honorary Board of Trustees

Association for Corporate Growth (ACG) Philadelphia, Past Board Member

Education

University of Pennsylvania Law School (J.D., cum laude)
Senior Editor, University of Pennsylvania Law Review; Member, Order of the Coif

University of Michigan (M.B.A., with honors)
Member, Beta Gamma Sigma

University of Delaware (B.A., magna cum laude)

Lawyer Rankings

United States > M&A/corporate and commercial > M&A: middle-market (sub-$500m)

With a strong national footprint, Ballard Spahr LLP demonstrates strength advising buyers and sellers – ranging from privately held companies to multinational public corporations and private equity funds – on middle and lower-middle market M&A. Brian Doerner, who is a key contact for life sciences transactions in the Philadelphia office, and Barbara Rummel in Minneapolis, who has completed numerous transactions involving public and privately held businesses, serve as co-leaders of the firm’s M&A group. Co-head of the private equity practice Maggie Tatton in Minneapolis and Gregory Seltzer, who oversees the emerging companies and venture capital department, are other key contacts. Based in Phoenix, Karen McConnell specializes in corporate and securities law, and has a wealth of experience in both strategic M&A and private equity investments.